跳至主要内容
临床试验/NCT06170918
NCT06170918尚未招募不适用

Half Effective Dose of Remimazolam to Prevent Cardiovascular Response to Tracheal Intubation When Combined With Fentanyl

Zhihong LU0 个研究点目标入组 40 人开始时间: 2023年12月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
40
主要终点
half effective dose for intubation

研究概览

简要总结

Remimazolam has demonstrated the potential as a valuable medication for procedural sedation and general anesthesia. However, half effective dose of remimazolam required to prevent cardiovascular response to tracheal intubation when combined with fentanyl in pediatric patients is still unknown.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Sequential
主要目的
Treatment
盲法
None

入排标准

年龄范围
3 Years 至 12 Years(Child)
性别
All
接受健康志愿者

入选标准

  • age from 3 to 12 years old
  • patients scheduled for surgery under general anesthesia
  • Body mass index in the range of 5% -95% of the same age group
  • Consent was obtained from the patient and the family members, and an informed consent form was signed

排除标准

  • American Society of Anesthesiologists status ≥3
  • patients who cannot cooperate with intravenous anesthesia induction
  • patients with risk of difficult airway
  • patients who are allergic to benzodiazepines
  • patients with neurological dysfunction
  • Participate involved in other clinical investigators within 3 months

研究组 & 干预措施

remimazolam

Experimental

Remimazolam is given for anesthesia induction. The initial dosage is 0.4mg/kg, and the interval dosage is 0.02mg/kg.

干预措施: Remimazolam (Drug)

结局指标

主要结局

half effective dose for intubation

时间窗: from injection of remimazolam to completed tracheal intubation, at an average of 5 minutes

half effective dose of remimazolam required to prevent cardiovascular response to tracheal intubation when combined with fentanyl

cardiovascular response to tracheal intubation

时间窗: from injection of remimazolam to 3 minutes after tracheal intubation, at an average of 8 minutes

cardiovascular response is defined as increase of blood pressure or heart rate higher than 20% of the baseline value by 3 minutes after intubation

次要结局

  • the time to loss of consciousness(from injection of remimazolam to loss of consciousness, at an average of 3 minutes)
  • incidence of adverse events(from injection of remimazolam to loss of consciousness, at an average of 3 minutes)

研究者

发起方
Zhihong LU
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Zhihong LU

Associate professor

Air Force Military Medical University, China

相似试验